[1] Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease[J]. J Clin Invest, 2011, 121(6):2111-2117. [2] Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes[J]. Clin Endocrinol (Oxf), 2010, 72(3):342-348. [3] Ernst MC, Sinal CJ. Chemerin:at the crossroads of inflammation and obesity[J]. Trends Endocrinol Metab, 2010, 21(11):660-667. [4] Li Y, Shi B, Li S. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome:a meta-analysis[J]. PloS One, 2014, 9(12):e113915. [5] Han J, Kim SH, Suh YJ, et al. Serum Chemerin Levels Are Associated with Abdominal VisceralFat in Type 2 Diabetes[J]. J Korean Med Sci, 2016, 31(6):924-931. [6] Ernst MC, Issa M, Goralski KB, et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes[J]. Endocrinol, 2010, 151(5):1998-2007. [7] Lee MK, Chu SH, Lee DC, et al. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults[J]. Clin Chim Acta, 2013, 421:109-115. [8] Kim SH, Lee SH, Ahn KY, et al. Effect of lifestyle modification on serum chemerin concentrationand its association with insulin sensitivity in overweight and obese adults with type 2 diabetes[J]. Clin Endocrinol (Oxf), 2014, 80(6):825-833. [9] Chakaroun R, Raschpichler M, Kloting N, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity[J]. Metabolism, 2012, 61(5):706-714. [10] Stefanov T, Bluher M, Vekova A, et al. Circulating chemerin decreases in response to a combined strength and endurance training[J]. Endocrine, 2014, 45(3):382-391. [11] Neuparth MJ, Proenca JB, Santos-Silva A, et al. The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus[J]. J Investig Med, 2014, 62(2):350-353. [12] Malin SK, Navaneethan SD, Mulya A, et al. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults[J]. J Nutr Health Aging, 2014, 18(6):608-615. [13] Chakaroun R, Raschpichler M, Kloting N, et al. Effe cts of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity[J]. Metabolism, 2012, 61(5):706-714. [14] Ress C, Tschoner A, Engl J, et al. Effect of bariatric surg ery on circulating chemerin levels[J]. Eur J Clin Invest, 2010, 40(3):277-280. [15] Schultz S, Beck-Sickinger AG. Chemerin and vaspin:possible targ ets to treat obesity[J]. Chem Med Chem, 2013, 8(4):549-559. [16] Ernst MC, Haidl ID, Zuniga LA, et al. Disruption of the Che mokine-Like Rec eptor-1(CMKLR1) Gene Is Associated with Reduced Adiposity and Glucose Intolera nce[J]. Endocrinology, 2012, 153(2):672-682. [17] Huang C, Wang M, Ren L, et al. CMKLR1 deficiency influences glucose tolera nce and thermogenesis in mice on high fat diet[J]. Biochem Biophys Res Comm un, 2016, 473(2):435-441. [18] Wargent ET, Zaibi MS, O'Dowd JF, et al. Evidence from studi es in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes[J]. PeerJ, 2015, 3:e753. [19] Bondue B, De Henau O, Luangsay S, et al. The chemerin/ChemR 23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo[J]. PloS One, 2012, 7(6):e40043. |